ROCKET PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Rocket Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Rocket Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $4.55M, a 4.74% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.55M +$206K +4.74% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $4.77M +$4.57M +2284% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $3.9M +$1.93M +97.8% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $4.09M +$3.07M +300% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $4.35M +$3.14M +260% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $200K -$1.19M -85.6% Mar 31, 2023 10-K 2024-02-27
Q4 2022 $1.97M +$403K +25.7% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $1.02M -$445K -30.3% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $1.21M -$421K -25.9% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $1.39M -$397K -22.2% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $1.57M +$655K +71.7% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $1.47M +$373K +34.1% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $1.63M +$358K +28.2% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $1.79M +$317K +21.6% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $914K -$1.14M -55.4% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $1.09M -$1.16M -51.5% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $1.27M -$1.18M -48.2% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $1.47M -$1.18M -44.5% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $2.05M +$2.05M Dec 31, 2019 10-K 2021-03-01
Q3 2019 $2.25M Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $2.45M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $2.65M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.